Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
12/2004
12/15/2004EP1226125B1 Method for producing therapeutic agents for ulcers
12/15/2004CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/14/2004US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004CA2118378C Preparation of 5-acetoacetylamino-2-benzimidazolone
12/09/2004WO2004107477A2 Conductive membranes formed from silanes having functional groups
12/09/2004WO2004106493A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
12/09/2004US20040249185 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
12/09/2004US20040249166 Novel surfactants
12/09/2004US20040248958 Heterocyclic amide derivatives
12/09/2004US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004US20040248899 Fused bicyclic-substituted amines as histamine-3 receptor ligands
12/09/2004US20040248895 Novel guanidino compounds
12/09/2004US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine
12/09/2004US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/08/2004EP1484640A1 Surfactants for use in light-insensitive thermographic recording materials
12/08/2004EP1484323A1 2-thiosubstituted benzimidazole derivatives as surfactants for photographic application
12/08/2004EP1483228A1 Nk1 antagonists
12/08/2004EP1482944A2 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
12/07/2004CA2147755C 6-(substituted methylene) penems and intermediates
12/02/2004WO2004103976A2 Method for synthesising heterocyclic compounds from thiourea derivatives
12/02/2004WO2004103282A2 Compounds, compositions and methods
12/02/2004WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004US20040242578 Pyrimidineamines as angiogenesis modulators
12/02/2004US20040242560 Process for synthesizing heterocyclic compounds
12/02/2004DE10320326A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
12/02/2004CA2532059A1 Triaza-spiro compounds as nociceptin analogues and uses thereof
12/02/2004CA2526646A1 Method for synthesising heterocyclic compounds from thiourea derivatives
12/01/2004EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004EP1481002A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/01/2004EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004CN1551879A Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/01/2004CN1551870A Heterocyclic amide derivative and use as pesticide
12/01/2004CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004CN1177830C Benzoheterocycles and their use as MEK inhibitors
11/2004
11/30/2004US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004US6825223 Anilide compounds and pharmaceutical compositions comprising them
11/30/2004US6825219 Substituted benzimidazole compounds
11/30/2004US6824570 Chromatic direct dyes of 2-azo benzimidazole, benzothiazole or benzoxaozle derivatives
11/25/2004WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004WO2004100881A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004WO2004100875A2 Benzimidazoles, compositions containing such compounds and methods of use
11/25/2004WO2004100865A2 New benzimidazole derivatives
11/25/2004WO2004089942A3 Benzimidazolidinone derivatives as muscarinic agents
11/25/2004US20040236113 Process for manufacture of telmisartan
11/25/2004US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004US20040235870 Protein kinase inhibitors
11/25/2004US20040235836 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/25/2004US20040234622 Sulfonamide derivatives
11/25/2004CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004CA2524470A1 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004CA2524436A1 Benzimidazoles, compositions containing such compounds and methods of use
11/24/2004EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004EP1479666A1 Ester compound and medicinal use thereof
11/24/2004EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004CN1548424A Prepn of 1-((2-cyanobiphenyl-4-radical)methyl)-2-ethoxylbenzimidazole-7- ethyl formate as candixatan ester intermediate
11/23/2004US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/18/2004WO2004100525A2 System and method for blocking television signal having multiple different content ratings
11/18/2004WO2004099131A2 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/18/2004WO2004098516A2 Cyclic derivatives as modulators of chemokine receptor activity
11/18/2004WO2004054515A3 Thrombopoietin mimetics
11/18/2004US20040229955 Antibacterial agents
11/18/2004US20040229889 HDAC inhibitor
11/18/2004US20040229874 5HT7 Antagonists and inverse agonists
11/18/2004CA2531869A1 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/17/2004EP1476445A1 Tricyclic n-acyl compounds
11/17/2004EP1476423A2 Arylsulfonamidobenzylic compounds
11/11/2004WO2004096784A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1).
11/11/2004WO2004087690A3 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
11/11/2004WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004US20040225129 Process for preparing and purifying 1,7'-dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole
11/11/2004US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004US20040224997 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/11/2004US20040224993 Diphenylurea compounds
11/11/2004US20040224955 Viral polymerase inhibitors
11/11/2004US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/10/2004EP1474400A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)] -6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
11/10/2004CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 154